DYN
Price
$9.02
Change
-$0.38 (-4.04%)
Updated
Jul 18 closing price
Capitalization
1.28B
10 days until earnings call
PCVX
Price
$36.21
Change
-$0.36 (-0.98%)
Updated
Jul 18 closing price
Capitalization
4.67B
22 days until earnings call
Interact to see
Advertisement

DYN vs PCVX

Header iconDYN vs PCVX Comparison
Open Charts DYN vs PCVXBanner chart's image
Dyne Therapeutics
Price$9.02
Change-$0.38 (-4.04%)
Volume$1.69M
Capitalization1.28B
Vaxcyte
Price$36.21
Change-$0.36 (-0.98%)
Volume$1.19M
Capitalization4.67B
DYN vs PCVX Comparison Chart in %
Loading...
DYN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PCVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DYN vs. PCVX commentary
Jul 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DYN is a Hold and PCVX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 21, 2025
Stock price -- (DYN: $9.02 vs. PCVX: $36.21)
Brand notoriety: DYN and PCVX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DYN: 61% vs. PCVX: 71%
Market capitalization -- DYN: $1.28B vs. PCVX: $4.67B
DYN [@Biotechnology] is valued at $1.28B. PCVX’s [@Biotechnology] market capitalization is $4.67B. The market cap for tickers in the [@Biotechnology] industry ranges from $286.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DYN’s FA Score shows that 1 FA rating(s) are green whilePCVX’s FA Score has 0 green FA rating(s).

  • DYN’s FA Score: 1 green, 4 red.
  • PCVX’s FA Score: 0 green, 5 red.
According to our system of comparison, PCVX is a better buy in the long-term than DYN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DYN’s TA Score shows that 5 TA indicator(s) are bullish while PCVX’s TA Score has 5 bullish TA indicator(s).

  • DYN’s TA Score: 5 bullish, 5 bearish.
  • PCVX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, PCVX is a better buy in the short-term than DYN.

Price Growth

DYN (@Biotechnology) experienced а +4.40% price change this week, while PCVX (@Biotechnology) price change was +0.78% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.68%. For the same industry, the average monthly price growth was +13.07%, and the average quarterly price growth was +34.43%.

Reported Earning Dates

DYN is expected to report earnings on Jul 31, 2025.

PCVX is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+2.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PCVX($4.67B) has a higher market cap than DYN($1.28B). PCVX YTD gains are higher at: -55.766 vs. DYN (-61.715). DYN has higher annual earnings (EBITDA): -395.31M vs. PCVX (-512.62M). PCVX has more cash in the bank: 1.67B vs. DYN (677M). DYN has less debt than PCVX: DYN (23.3M) vs PCVX (87.2M). DYN (0) and PCVX (0) have equivalent revenues.
DYNPCVXDYN / PCVX
Capitalization1.28B4.67B27%
EBITDA-395.31M-512.62M77%
Gain YTD-61.715-55.766111%
P/E RatioN/AN/A-
Revenue00-
Total Cash677M1.67B40%
Total Debt23.3M87.2M27%
TECHNICAL ANALYSIS
Technical Analysis
DYNPCVX
RSI
ODDS (%)
Bullish Trend 3 days ago
77%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
79%
Momentum
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
67%
MACD
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
78%
Advances
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
79%
Declines
ODDS (%)
Bearish Trend 10 days ago
88%
Bearish Trend 14 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
76%
Aroon
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
DYN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PCVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PPTAX17.240.06
+0.35%
Virtus KAR Global Quality Dividend A
KTCIX51.090.05
+0.10%
DWS Science and Technology Inst
ESERX34.870.03
+0.09%
Eaton Vance Atlanta Capital Sel Eq R6
PMIRX10.860.01
+0.09%
Putnam Multi-Asset Income R
PJFZX75.38-0.06
-0.08%
PGIM Jennison Growth Z

PCVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PCVX has been loosely correlated with DNLI. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if PCVX jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PCVX
1D Price
Change %
PCVX100%
-0.98%
DNLI - PCVX
44%
Loosely correlated
-3.65%
ORKA - PCVX
44%
Loosely correlated
-5.34%
KYMR - PCVX
40%
Loosely correlated
-0.37%
DYN - PCVX
40%
Loosely correlated
-4.04%
TSHA - PCVX
40%
Loosely correlated
-0.77%
More